Gencove Raises $10 Million to Meet the Global Demand for Accessible and Interpretable Whole Genome Sequencing at Scale
- Tuesday, October 26, 2021, 7:02
- Finance
- Add a comment
NEW YORK, Oct. 26, 2021 /PRNewswire/ — Gencove, the leading low-pass genome sequencing platform company, today announced the successful close of a $10 million Series A investment bringing the company’s total financing to $16.2 million. The round was led by Lewis & Clark AgriFood with…